Author:
Bavuu Oyunbileg,Fukuda Daiju,Ganbaatar Byambasuren,Matsuura Tomomi,Ise Takayuki,Kusunose Kenya,Yamaguchi Koji,Yagi Shusuke,Yamada Hirotsugu,Soeki Takeshi,Wakatsuki Tetsuzo,Sata Masataka
Reference48 articles.
1. Adipose tissue and insulin resistance in obese;Ahmed;Biomed. Pharmacother.,2021
2. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist;Arai;Eur. J. Pharmacol.,2015
3. Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker;Arai;Hypertens. Res.,2020
4. CS-3150, a novel nonsteroidal mineralocorticoid receptor antagonist, shows preventive and therapeutic effects on renal injury in deoxycorticosterone acetate/salt-induced hypertensive rats;Arai;J.Pharmacol.Exp. Ther.,2016
5. Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?;Asrih;Mol. Cell. Endocrinol.,2015
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献